|
⚲
|
| Teva Pharmaceutical Industries Ltd | |
|---|---|
| Ticker | TEVA |
| CIK # | 0000818686 |
| CUSIP | 881624209 |
| Sector | Life Sciences |
| Industry | Pharmaceutical Preparations |
| Phone | |
| Address | 5 Bazel St PO B 3190 Petach Tikva, 49131 |
| Source | [EDGAR] |
| Market Cap, 13F ($) |
|---|
| Business |
|---|
|
We are a global pharmaceutical company, committed to helping patients around the world to access affordable medicines and benefit from innovations to improve their health. Our mission is to be a global leader in generics, specialty medicines and biopharmaceuticals, improving the lives of patients. We operate worldwide, with headquarters in Israel and a significant presence in the United States, Europe and many other markets around the world. Our key strengths include our world-leading generic medicines expertise and portfolio, focused specialty medicines portfolio and global infrastructure and scale. Teva was incorporated in Israel on February 13, 1944 and is the successor to a number of Israeli corporations, the oldest of which was established in 1901. |
| CIK | Filing | 2011 - 2023 |
|---|---|---|
| [0000818686] | 10-K | |
| [0000818686] | 10-Q | |
| [0000818686] | 3 | |
| [0000818686] | 4 | |
| [0000818686] | 5 | |
| [0000818686] | 6-K | |
| [0000818686] | 8-K | |
| [0000818686] | SC 13D | |
| [0000818686] | SC 13G |